Table 2.

Patient demographics

Subjects (n)27
Age (y)
    Median58
    Range27-74
Gender, n (%)
    Male19 (70)
    Female8 (30)
Karnofsky performance status, n (%)
    70-<905 (19)
    90-10022 (81)
Histology (n)
    Non–small cell lung cancer5
    Colon5
    Renal3
    Pancreatic3
    Melanoma3
    Adrenal2
    Hepatobiliary2
    Unknown2
    Prostate1
    Sarcoma1
Prior treatment, n (%)
    Chemotherapy24 (89)
    Taxane6 (22)
    Surgery25 (93)
    Radiation13 (48)